MarkNtel Advisors, a leading market research and consulting firm, has announced the release of its latest study titled Type-2 Diabetes Market Research Report: Forecast (2025–2030). This report provides a detailed assessment of the Type-2 Diabetes, covering its evolving dynamics, emerging trends, key growth drivers, major challenges, and competitive landscape.

Designed to guide investors, stakeholders, and business leaders, the research aims to deliver valuable insights for strategic planning, risk assessment, and investment decision-making in the years ahead.

Market Timeline Overview

• Historical Years: 2021–24
• Base Year: 2025
• Forecast Years: 2025–32

This helps businesses identify emerging opportunities, assess market risks, and develop data-driven strategies for long-term success.

Download a FREE PDF Sample of the Report: - https://www.marknteladvisors.com/query/request-sample/global-type-2-diabetes-market.html  (Discover the market potential, platform-specific insights, and key industry trends.)

In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2026 to 2032, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Type-2 Diabetes Market Outlook

The Global Type-2 Diabetes Market size was valued at around USD 52.7 billion in 2024 and is expected to reach USD 72.21 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 5.39% during the forecast period, i.e., 2025-30.

The market growth is favorably fostered by the increasing prevalence of type 2 diabetes stemming from unhealthy lifestyles, physical inactivity, and obesity. According to WHO, around 422 million people worldwide have diabetes, out of which the majority live in low-and middle-income countries. In addition, diabetes accounts for more than 1.5 million deaths each year. The number of cases and the prevalence of diabetes have witnessed expansion over the past few decades.  In addition, the rising geriatric population, along with the surging population with type-1 diabetes and the lack of proper healthcare infrastructure in emerging countries, are projected to boost the growth of the type-2 Diabetes market globally in the forthcoming years.

Type-2 Diabetes Market Drivers:

Rising Global Prevalence of Obesity and Sedentary Lifestyle – A key driver for the Global Type-2 Diabetes Market is the increasing prevalence of obesity and sedentary lifestyles worldwide. Urbanization, changing dietary habits, and reduced physical activity are leading to a surge in obesity rates, which is a major risk factor for type 2 diabetes. This trend is particularly pronounced in both developed and developing nations, contributing to a growing patient pool and heightened demand for diabetes management solutions. As more individuals are diagnosed with type 2 diabetes, the market for medications, monitoring devices, and support services continues to expand rapidly.

View Full Report (All Data, In One Place): - https://www.marknteladvisors.com/research-library/global-type-2-diabetes-market.html   (Explore in-depth analyses, technological trends, and investment patterns.)

Type-2 Diabetes Market Trends:

Adoption of Digital Health and Remote Monitoring Solutions – A prominent trend in the Type-2 Diabetes Market is the adoption of digital health technologies and remote monitoring solutions. Patients and healthcare providers are increasingly utilizing mobile apps, wearable devices, and telemedicine platforms to track blood glucose levels, manage medication adherence, and receive personalized health recommendations. These innovations are improving disease management, patient engagement, and early intervention, while also reducing the burden on healthcare systems. The integration of digital tools is transforming traditional diabetes care into a more proactive and patient-centered approach.

Type-2 Diabetes Market Segmentation

The study categorizes the Type-2 Diabetes into various segments and sub-segments, each analyzed for its size, growth potential, and contribution to the overall industry.

By Drug Type

• Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
• Alpha-glucosidase Inhibitors
• Biguanides
• Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
• Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2)
• Sulfonylureas
• Other (Thiazolidinediones, Meglitinides, Glitazones, etc.)

By Gender

• Male
• Female

By Age Group

• Upto 19 years
• 20 – 65 years
• Above 65 years

Geographical Analysis

The report presents detailed insights into the market’s geographical expansion, highlighting key trends and opportunities across the following geographies:

By Region

• North America
• South America
• Europe
• Middle East & Africa
• Asia-Pacific.

Talk to Our Industry Analyst:  - https://www.marknteladvisors.com/query/talk-to-our-consultant/global-type-2-diabetes-market.html  Get personalized insights into company strategies and regional market dynamics.)

Leading Companies in Type-2 Diabetes Market Worldwide: Players, Analysis & Future Outlook

• Merck & Co
• AstraZeneca
• Novo Nordisk
• Bristol-Myers Squibb
• Eli Lilly
• Sanofi
• Boehringer Ingelheim
• Pfizer
• Takeda
• Biocon
• Johnson & Johnson.

Key Highlights of the Report

• Comprehensive Market Overview: In-depth analysis of market size, share, and forecasts from 2025 to 2030.
• Growth Drivers & Challenges: Clear insights into factors feeling or restraining market expansion.
• Investment & Regulatory Insights: Evaluation of key policies, funding trends, and collaborations influencing industry performance.
• Competitive Landscape: Detailed profiles of leading companies, including product portfolios, business strategies, financials, and recent developments such as mergers & acquisitions.

Analytical Tools: Application of SWOT Analysis, PESTEL Analysis, and Porter’s Five Forces Model to assess competition and external influences

Browse through our flexible pricing plans and choose the package that best fits your business needs whether you require a single-user license, corporate access, or customized insights. Once you select the plan that suits your requirements, you can purchase and instantly access the full report online – https://www.marknteladvisors.com/pricing/global-type-2-diabetes-market.html   

Frequently Asked Questions (FAQ)

1. What is the projected growth rate of the Type-2 Diabetes?
   2. What are the major factors driving this market’s growth?
   3. Which regions are expected to lead the Type-2 Diabetes?
   4. Who are the prominent players in the Type-2 Diabetes?
   5. How is the competition structured in this market?
   6. How can I access the full report?

About Us

MarkNtel Advisors is a globally recognized market research and consulting firm delivering intelligence across the healthcare industry, spanning pharmaceuticals, medical devices, healthcare IT, and biotechnology. Our analysts combine domain expertise with innovation tracking to help healthcare organizations improve efficiency and patient outcomes. Through Consulting Services, we assist clients in interpreting insights, designing go-to-market strategies, and adapting to regulatory changes, fostering sustainable growth in the evolving global healthcare ecosystem.

Contact Us:
MarkNtel Advisors
Sector 63, Noida, Uttar Pradesh-201301, India
Contact No: +91 87199 99009
Email: sales@marknteladvisors.com
Website: https://www.marknteladvisors.com